Outcomes in stage i non-small cell lung cancer following the introduction of stereotactic body radiotherapy in Alberta - A population-based study

Radiotherapy and Oncology

Volumn 117, Issue 1, 2015, Pages 71-76

  Liu, Hong Wei ^a,e,f   Gabos, Zsolt ^b,e   Ghosh, Sunita ^b,e   Roberts, Barbara ^c   Lau, Harold ^d,f   Kerba, Marc ^d,f  

^a Central Alberta Cancer Center   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

^c ALBERTA HEALTH SERVICES   (Canada)

^d TOM BAKER CANCER CENTRE   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

Author keywords

Concordance statistic; Lung SBRT; Overall survival; Population study; Stage I NSCLC

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; FEMALE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL PATIENT; TREATMENT OUTCOME; VERY ELDERLY; ALBERTA; CARCINOMA, NON-SMALL-CELL LUNG; EPIDEMIOLOGY; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RADIOSURGERY; REGISTER; UTILIZATION;

ADULT; AGED; AGED, 80 AND OVER; ALBERTA; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; REGISTRIES; TREATMENT OUTCOME;

EID: 84946483766     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.08.027     Document Type: Article

References (39)

1. D.J. Raz, J.A. Zell, S.H. Ou, D.R. Gandara, H. Anton-Culver, and D.M. Jablons Natural history of stage I non-small cell lung cancer: implications for early detection Chest 132 2007 193 199
2. J.Y. Chang, S. Senan, M.A. Paul, and et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials Lancet Oncol 16 2015 630 637
3. F. Solda, M. Lodge, S. Ashley, A. Whitington, P. Goldstraw, and M. Brada Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort Radiother Oncol 109 2013 1 7
4. N.P. Nguyen, L. Garland, J. Welsh, R. Hamilton, D. Cohen, and V. Vinh-Hung Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma Cancer Treat Rev 34 2008 719 727
5. A.V. Louie, D.A. Palma, M. Dahele, G.B. Rodrigues, and S. Senan Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons Radiother Oncol 114 2015 138 147
6. M. Brada, A. Pope, and M. Baumann SABR in NSCLC-the beginning of the end or the end of the beginning? Radiother Oncol 114 2015 135 137
7. L.L. van den Berg, T.J. Klinkenberg, H.J. Groen, and J. Widder Patterns of recurrence and survival after surgery or stereotactic radiotherapy for early stage NSCLC J Thorac Oncol 10 2015 826 831
8. R.D. Timmerman, C. Park, and B.D. Kavanagh The North American experience with stereotactic body radiation therapy in non-small cell lung cancer J Thorac Oncol 2 2007 S101 S112
9. M. Taremi, A. Hope, M. Dahele, and et al. Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients Int J Radiat Oncol Biol Phys 82 2012 967 973
10. F. Baba, Y. Shibamoto, H. Ogino, and et al. Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size Radiat Oncol 5 2010 81
11. I.S. Grills, A.J. Hope, M. Guckenberger, and et al. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy J Thorac Oncol 7 2012 1382 1393
12. A.V. Louie, G.B. Rodrigues, D.A. Palma, and S. Senan Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada Oncologist 19 2014 880 885
13. R. Clayton, H. Liu, R. Khan, and et al. Implementation of lung stereotactic ablative radiotherapy at a regional cancer center J Med Imaging Radiat Oncol 43 2012 245 252
14. S.L. Smith, D. Palma, T. Parhar, C.S. Alexander, and E.S. Wai Inoperable early stage non-small cell lung cancer: comorbidity, patterns of care and survival Lung Cancer 72 2011 39 44
15. Liu L, Forman S, Barton B. Fitting Cox Model Using PROC PHREG and Beyond in SAS; 2009. p. 236
16. Health Information Systems. http://multimedia.3m.com/mws/media/828410O/faqs-3m-clinical-risk-groups-crgs-11-12.pdf?fn=crg-faqs-with-pagination.pdf. 2012; 2015.
17. F.E. Harrell Jr, K.L. Lee, and D.B. Mark Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors Stat Med 15 1996 361 387
18. E.W. Steyerberg, F.E. Harrell Jr, G.J. Borsboom, M.J. Eijkemans, Y. Vergouwe, and J.D. Habbema Internal validation of predictive models: efficiency of some procedures for logistic regression analysis J Clin Epidemiol 54 2001 774 781
19. W. Hopmans, L. Zwaan, S. Senan, and et al. Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: a binary choice experiment Radiother Oncol 115 2015 361 366
20. O. Birim, A.P. Kappetein, and A.J. Bogers Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer Eur J Cardiothorac Surg 28 2005 759 762
21. D. Moro-Sibilot, A. Aubert, S. Diab, and et al. Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer Eur Respir J 26 2005 480 486
22. D. Grose, D.S. Morrison, G. Devereux, and et al. The impact of comorbidity upon determinants of outcome in patients with lung cancer Lung Cancer 87 2015 186 192
23. C.Y. Wang, Y.S. Lin, C. Tzao, and et al. Comparison of Charlson comorbidity index and Kaplan-Feinstein index in patients with stage I lung cancer after surgical resection Eur J Cardiothorac Surg 32 2007 877 881
24. M. Luchtenborg, E. Jakobsen, M. Krasnik, K.M. Linklater, A. Mellemgaard, and H. Moller The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients Eur J Cancer 48 2012 3386 3395
25. T. Antoniou, R. Ng, R.H. Glazier, A. Kopp, and P.C. Austin Comparison of comorbidity classification methods for predicting outcomes in a population-based cohort of adults with human immunodeficiency virus infection Ann Epidemiol 24 2014 532 537
26. P.C. Austin, C. van Walraven, W.P. Wodchis, A. Newman, and G.M. Anderson Using the Johns Hopkins Aggregated Diagnosis Groups (ADGs) to predict mortality in a general adult population cohort in Ontario, Canada Med Care 49 2011 932 939
27. D. Vivas-Consuelo, R. Uso-Talamantes, N. Guadalajara-Olmeda, J.L. Trillo-Mata, C. Sancho-Mestre, and L. Buigues-Pastor Pharmaceutical cost management in an ambulatory setting using a risk adjustment tool BMC Health Serv Res 14 2014 462
28. J.S. Hughes, R.F. Averill, J. Eisenhandler, and et al. Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management Med Care 42 2004 81 90
29. B. Zhang, F. Zhu, X. Ma, and et al. Matched-pair comparisons of stereotactic body radiotherapy (SBRT) versus surgery for the treatment of early stage non-small cell lung cancer: a systematic review and meta-analysis Radiother Oncol 112 2014 250 255
30. J. Widder, D. Postmus, J.F. Ubbels, E.M. Wiegman, and J.A. Langendijk Survival and quality of life after stereotactic or 3D-conformal radiotherapy for inoperable early-stage lung cancer Int J Radiat Oncol Biol Phys 81 2011 e291 e297
31. N.C. van der Voort van Zyp, J.B. Prevost, and M.S. Hoogeman Stereotactic radiotherapy with real-time tumor tracking for non-small cell lung cancer: clinical outcome Radiother Oncol 91 2009 296 300
32. F.B. Zimmermann, H. Geinitz, S. Schill, and et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC) Acta Oncol 45 2006 796 801
33. T. Xia, H. Li, Q. Sun, and et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer Int J Radiat Oncol Biol Phys 66 2006 117 125
34. S.M. Shirvani, J. Jiang, J.Y. Chang, and et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly Int J Radiat Oncol Biol Phys 84 2012 1060 1070
35. D. Palma, and S. Senan Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer Curr Opin Oncol 23 2011 133 139
36. D. Palma, F. Lagerwaard, G. Rodrigues, C. Haasbeek, and S. Senan Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review Int J Radiat Oncol Biol Phys 82 2012 1149 1156
37. M. Koshy, R. Malik, M. Spiotto, U. Mahmood, R. Weichselbaum, and D. Sher Disparities in treatment of patients with inoperable stage I non-small cell lung cancer: a population-based analysis J Thorac Oncol 10 2015 264 271
38. D. Palma, O. Visser, F.J. Lagerwaard, J. Belderbos, B.J. Slotman, and S. Senan Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis J Clin Oncol 28 2010 5153 5159
39. C.J. Haasbeek, D. Palma, O. Visser, F.J. Lagerwaard, B. Slotman, and S. Senan Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands Ann Oncol 23 2012 2743 2747